EVAXION BIOTECH A/S — Credit Rating and Financial Key Figures

EVAXION BIOTECH A/S (CVR number: 31762863K) is a company from RUDERSDAL. The company reported a net sales of 0.5 mDKK in 2023. The operating profit percentage was poor at -30156.8 % (EBIT: -152.9 mDKK), while net earnings were -152.4 mDKK. The profitability of the company measured by Return on Assets (ROA) was -107.4 %, which can be considered poor and Return on Equity (ROE) was -210.5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 30.4 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. EVAXION BIOTECH A/S's liquidity measured by quick ratio was 1.2 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.